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Abstract 
The kinetics of cGMP-binding to the major cGMP-binding activity in Dictyostelium were investigated in 10 non-chemotactic mutants 
(KI mutants; KI-1 ~ 10). A wild-type cell contains about 3000 binding sites with a K d of 1.5 nM. cGMP may dissociate from these 
binding sites with fast (F-type) or slow (S-type) kinetics, and DNA has been shown to promote the conversion of F- to S-type of 
cGMP-binding. The 10 mutants were placed in 4 classes, based on equilibrium and non-equilibrium binding properties and the effect of 
DNA. Class I mutants (KI-1, 3 and 8) have normal cGMP-binding properties. Class II mutants (KI-2, 6 and 7) show increased K a values 
but nearly normal Bmax, normal F/S ratio and normal effects of DNA. Class III mutants (KI-4, 5 and 10) have a strongly decreased K a 
and increased Bmax, nearly all binding sites are of the S-type and DNA does not affect the binding; apparently these mutants have a 
cGMP-binding protein locked in the S-form. cGMP-binding in class IV mutant (KI-9) is normal except hat the number of binding sites is 
increased about 3-fold. The finding of seven mutants with altered cGMP-binding in 10 non-chemotactic mutants suggests that the 
cGMP-binding activity plays an important role in the chemotactic signal transduction pathway. 
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1. Introduction 
Two compounds are known as chemoattractants in the 
amoeboid micro-organism Dictyostelium discoideum (re- 
viewed in Ref. [2]). Folic acid, a secreted compound from 
the food source bacteria is a chemoattractant which acts 
mainly in the vegetative stage of the life cycle [17]. After 
removal of bacteria, folic acid ceases to induce a chemo- 
tactic response. Instead, cAMP, secreted by D. discoideum 
cells themselves, becomes a chemoattractant functioning as 
the main trigger to induce a developmental program: cell 
aggregation, multicellular organization and the formation 
of fruiting bodies [7]. 
Folic acid and cAMP are detected by different surface 
receptors, which are coupled to different G-proteins [6]. 
Various responses uch as a transient increase of intra- 
cellular cGMP and the association of actin and conven- 
tional myosin to the cytoskeleton are observed when cells 
Abbreviations: cAMP, cyclic adenosine 3',5'-monophosphate; cGMP, 
cyclic guanosine 3',5'-monophosphate. 
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are stimulated with either folic acid or cAMP (reviewed in 
Refs. [5,16]). This led to the assumption that the folic acid 
and cAMP chemotactic signal transduction pathways tart 
at different receptors but combine into one common path- 
way [ 12,26]. 
Based on this assumption, non-chemotactic mutants 
were isolated which do not respond to both folic acid and 
cAMP with the aim to unravel the part of the signal 
transduction pathway that is shared by different chemoat- 
tractants (KI-mutants). Chemotaxis is a complex process 
involving movement and orientation of a cell which are 
both regulated by extracellular signals. In chemotactic 
mutants selected from a large pool of 10000 randomly 
mutated cells, it may be expected that proteins involved in 
different second messenger systems can be found to be 
mutated, for instance cGMP, cAMP, Ca 2+, inositol phos- 
phates, and protein kinases. In this context it is surprising 
that several mutants have an altered cGMP response (see 
Table 1), suggesting that cGMP plays a central role in the 
regulation of chemotaxis; notably, KI-8 has strongly re- 
duced levels of guanylyl cyclase activity, whereas this 
enzyme is present but cannot be activated by cAMP in 
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Table 1 
Properties of chemotaxis KI mutants 
Strain Responses Biochemical properties 
chemotaxis cGMP cGMP-PDE GC 
XP55 +++ +++ +++ +++ 
KI-I + + +++ +++ 
KI-2 - ++/de l*  +++ +++ 
KI-3 ++ +++ +++ +++ 
KI-4 - + + + + + + 
KI-5 - + + + + + + 
KI-6 - + + + + + + + 
KI-7 - +/de l  * + + + + + 
KI-8 - - + + + - 
KI-9 - + + + + + + 
- /++~ - +++ ++ KI-IO 
stmF + + + + + + - + + + 
XP-55 is the parental wild-type strain. Data are from Kuwayama et al. [9]. 
The properties of  mutant stmF are shown for comparison. + + +,  strong 
response/ large activity as in wild-type XP-55; + +,  strong, but signifi- 
cantly slightly reduced response/act iv i ty  if compared with XP-55; +,  
small, but still s ignif icant response /act iv i ty ;  - ,  insignif icant 
response/act iv i ty.  #, mutant KI-10 responds to some but not to other 
chemoattactants; *, delayed response with a maximum at 20 s, relative to 
10 s in wild-type XP55. 
mutant KI-10 [9]. All mutants howed similar activity of 
cGMP-specific phosphodJ, esterase, and all mutants, except 
KI-8, possess nearly normal guanylyl cyclase activity in 
vitro. 
The importance of cG1MP is supported by other observa- 
tions. First, all known Chemoattractants induce a similar 
transient increase of cGIVlP levels, not only folic acid and 
cAMP in D. discoideum but also other chemoattractants i  
other cellular slime mould species [4,13,28]. Second, a 
mutant called Streamer F, shows a prolonged chemotactic 
movement and, at the same time, a prolonged transient 
increase of cAMP-induced cGMP levels, due to a mutation 
in the cGMP-specific phosphodiesterase [20,23,3]. 
One important aspect of chemotactic movement is the 
regulation of sliding locomotion of myosin along actin 
filament [22]. This interaction between myosin and actin is 
organized by the formation and breakdown of actin and 
myosin filaments [8]. Myosin filament formation is regu- 
lated by myosin phosphorylation [29]. cGMP appears to be 
important for this process, because a cGMP response-less 
mutant (KI-10) does not ,;how a cAMP-induced increase of 
myosin phosphorylation [10], whereas myosin phospho- 
rylation is prolonged in mutant Streamer F with a defec- 
tive cGMP-phosphodiesterase [11 ].
Although the importance of cGMP for chemotaxis has 
been established, the target of cGMP leading to myosin 
phosphorylation is still unknown; it is likely to be a 
cGMP-binding protein. Previously, it was shown that the 
major cGMP-binding activity of Dictyostelium is de- 
tectable in the cytosol [14], and the binding activity is 
associated with neither cGMP-dependent protein kinase 
activity [18] nor cGMP-specific phosphodiesterase [24,18]. 
This binding activity was shown to exist in two forms: a 
slow dissociating type (S-type), and a fast dissociating type 
(F-type) [19]. Oligonucleotides promote the conversion 
from the F-type to the S-type of the cGMP-binding activ- 
ity. 
So far, there is no evidence that this cGMP-binding 
activity is associated with chemotactic signal transduction. 
In order to investigate the possible relationship between 
cGMP-binding activity and chemotaxis, we analyzed the 
cGMP-binding activity of the 10 non-chemotactic mutants 
and present evidence that the non-chemotactic phenotype 
of some mutants may be due to a defect in the cGMP-bind- 
ing activity. 
2. Materials and methods 
2.1. Materia& 
cAMP and cGMP were purchased from Boehringer. 
[8-3H]cGMP (910.2 GBq/mmol) was obtained from 
Amersham. Polycarbonate filters and nitrocellulose filters 
were from Nucleopore (Coster, Badhoevedorp, The 
Netherlands) and Schleicher and Schuell, respectively. 
2.2. Strains and culture condition 
KI mutants [9] and the parental strain XP-55 [15] were 
grown on 1/3 SM plates (0.3% glucose, 0.3% bactopep- 
tone, 40 mM KH2POa/N%HPO 4buffer pH 6.0 and 1.5% 
agar) with Klebsiella aerogenes. Cells were harvested in 
the late logarithmic phase with 10 mM KH2PO4/Na2HPO 4 
buffer (pH 6.5) (PB). Bacteria were removed by repeated 
centrifugations at 300 × g for 3 min. Then cells were 
starved for 5 h by shaking in PB at a density of 107 
cells/ml at 21°C. 
2.3. Preparation of supernatant 
For the cGMP-binding assay, starved cells were washed 
3 times in cGMP-binding assay buffer (40 mM 
Hepes/NaOH and 0.5 mM EDTA, pH 7.0), and resus- 
pended at a density of 2 × 108 cells/ml in the same buffer 
including 250 mM sucrose. Cells were then homogenized 
at 0°C by passed through a polycarbonate filter (pore size 
3 /~m). The homogenate was centrifuged at 4°C for 1 h at 
48 000 × g. The 48 000 × g supernatant was used for the 
cGMP-binding and the cGMP-dissociation experiments. 
2.4. cGMP-binding activity 
cGMP-binding to proteins in the supernatant was mea- 
sured as described previously [14,24,25]. Briefly, 100 /xl 
of the supernatant was added to an equal volume of 
binding mixture (100 mM PB, 6 mM MgCI2, 10 mM 
dithiothreitol and 0.5 nM, 1.5 nM, 3.0 nM or 6.0 nM 
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[8-3H]cGMP, at pH 6.0). After incubation for 15 min at 
0°C, the reactions were terminated by filtering the reaction 
mixture through a nitrocellulose filter (pore size 0.45 /~m). 
The filters were washed twice with 4 ml of 50 mM PB (pH 
6.0) and, after being dried, the radioactivity of the filters 
was measured in 4 ml of scintillant. Non-specific binding 
was measured by including 50 /zM unlabelled cGMP in 
the binding reaction; it was not significantly different 
between KI mutants and wild-type. Non-specific binding 
was subtracted from all data shown. 
2.5. Dissociation kinetics of  cGMP-binding 
The binding reaction was performed as described above 
with 3.75 nM labeled cGMP. The dissociation kinetics of 
the [3H]cGMP-protein complex was measured following 
addition of 50 /xl of unlabelled cGMP (100 ~M)  to 200 
/xl of this equilibrium binding mixture. The samples were 
filtrated through nitrocellulose filters at 0 min, 3 min or 15 
min after the addition of unlabelled cGMP. These binding 
assays were performed with or without 100 /~g/ml  dena- 
tured herring sperm DNA (boiled for 3 rain and immedi- 
ately cooled down on ice). 
3. Resu l t s  
3.1. cGMP-binding activity 
A cGMP-binding activity exists mainly in the soluble 
fraction of D. discoideum cell lysates [14]. Since cGMP is 
an important second messenger for chemotaxis in Dic- 
tyostelium, the cGMP-binding activity was analyzed in 
non-chemotactic mutants (KI mutants). 
The soluble fraction of lysates from all KI mutants were 
assayed for [3H]cGMP-binding activity. Non-specific bind- 
ing, measured in the presence on excess non-radioactive 
cGMP, was not different between lysates obtained from 
mutant and wild-type cells; non-specific binding is sub- 
tracted from all data shown. Using binding at different 
[3H]cGMP concentrations, Scatchard plots were obtained 
which show linear curves for all mutants as well as for the 
parental strain, XP55 (Fig. 1). This suggests that the 
cGMP-binding activity behaves in this assay as a single 
class of binding sites in every strain as was reported 
previously for other wild-type strains [14,25]. However, 
the slopes and/or  intercepts with the X-axis are very 
different in several mutants if compared to in the parental 
XP55 (Fig. 1). To address the differences clearly, apparent 
dissociation constants (K  d) and putative maximum number 
of binding sites (Bma x ) were  calculated for each strain 
from the Scatchard plots (Table 2). Using these data the 
mutants were placed in 4 groups according to their altered 
K d and Bma x values (Table 4). (I) KI-1, 3 and 8 show 
almost normal K d values and Bma x . (II) KI-2, 6 and 7 
show significantly higher K d values but have relatively 
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Fig. 1. Scatchard analysis of cGMP-binding in the cytosolic fraction of 
XP55 (O), KI-9 (zx), KI-4 ([]) and KI-7 (O). Equilibrium cGMP-bind- 
ing activity was determined in the soluble fraction of a lysate from the 
parental strain XP55 and three representative mutants as described in 
Section 2. The results hown here are not significantly different from the 
results of two other independent experiments. The slope of these curves 
represents - 1/K d and the intersection f the line with the X-axis yields 
the putative maximum number of binding sites (Bmax). The data for all 
mutants are presented in Table 2. 
normal or a slightly decreased Bma x . (III) KI-4, and 5 have 
significantly lower K d values as well as a strongly in- 
creased B~ax; KI-10 also shows this phenotype, although 
less strongly. (IV) KI-9 has a relatively normal K d value 
but a much higher number of binding sites. These results 
indicate that 7 of the 10 KI mutants possess aberrant 
equilibrium cGMP-binding properties. 
3.2. Dissociation kinetic of  cGMP-binding 
To determine if the aberrant Ko values of the cGMP- 
binding protein from the mutants are due to abnormal 
dissociation of cGMP from its binding protein, the dissoci- 
ation rate of the cGMP-protein complex was examined in 
each KI mutant. Data are presented as the binding ratio at 
Table 2 
cGMP-binding 
Strain K d Bma x 
nM sites/cell (% to XP55) 
XP55 1.56 + 0.27 2860 + 250 (100) 
KI-1 1.40+0.23 2340+ 140 (82) 
K1-2 2.40+0.16 * 2840-t- 150 (99) 
KI-3 1.41 _+0.39 2550+360 (89) 
KI-4 0.30-t-0.03 * * 4720-1-150 (165) * 
KI-5 0.50 _+ 0.08 * * 5360 + 300 (187) * 
KI-6 2.93 _+ 0.70 * 1950 + 300 (68) 
KI-7 3.28 + 0.46 * 2040 + 190 (71 ) 
KI-8 2.06+0.34 2510+250 (88) 
KI-9 1.12+0.31 7510_+910(263) * 
KI- 10 0.78 _+ 0.08 * * 9700_+ 350 (339) * 
K d and Bma x represent the dissociation constant and the putative maxi- 
mum number of binding sites per cell, respectively. All data shown are 
means with S.D. from triplicate determinations. *, significantly increased; 
* *, significantly decreased relative to XP55 with P < 0.05. 
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Fig. 2. Dissociation kinetics. Cytosolic fractions prepared from XP55 (A) and KI-4 (B) were incubated with 3.75 nM [3H]cGMP. The reactions were 
performed with (open symbols) or without (filled symbols) denatured herring sperm DNA (100/zg/ml).  At time 0 excess unlabelled cGMP was added and 
the residual binding of [3H]cGMP was measured at the times indicated. (C) Residual [3H]cGMP-binding of XP55 and all the KI mutants at 3 min after 
addition of the unlabelled cGMP without DNA. The results hown here are the mean 4- S.D. of two independent experiments with triplicate determinations. 
The data for all mutants are presented in Table 3. 
3 min or 15 min after addition of unlabelled cGMP 
compared to the binding before addition of cGMP. Fig. 2b 
shows that in a mutant, KI-4, the [3H]cGMP-protein com- 
plex dissociates much slower than in the parental strain 
(Fig. 2a). The data for all mutants are summarized in Fig. 
2c. In all mutants except KI-4, 5 and 10, more than 70% of 
Table 3 
Dissociation activities of cGMP-binding 
Strain Relative number of Relative binding after dissociation 
binding site,; with DNA * 3 min 15 min 
-DNA +DNA -DNA +DNA 
% to binding without DNA % to binding at t = 0 ( - or + DNA) 
XP55 161 4- 14 * 19 + 7 60 4- 10 7 4- 2 5 4- 2 
KI-I 1464- 16 * 294- 8 554-7 24+ 1 21 4- 1 
KI-2 125+ 14 * 264-5 45+ 1 21 4-2 304-2 
KI-3 180+ 10 * 95 :4  324-2 74- 1 74- 1 
KI-4 107 4- 21 75 + 5 65 4- 6 54 4- 2 55 + 4 
KI-5 89 4- 5 89 5:8 79 5:9 67 4- 11 64 + 12 
KI-6 1264-4 * 114-3 53+3 7+3 85:2 
KI-7 262+5 * 9+1 24+3 7+3 85:3 
KI-8 1134-2 * 174- 1 764-4 74-4  505:1 
1(1-9 229 4- 28 * 15 5:1 38 4- 5 16 4- 2 13 4- 1 
KI-10 129 4- 6 * 43 4- 4 43 4- 1 39 4- 4 29 4- 5 
The relative number of binding sites was determined at equilibrium with and without 100 /xg/ml DNA; the binding ratio +DNA/ -DNA is shown for 
each strain. Dissociation of the cGMP-protein complex is presented as the % of residual [3H]cGMP-binding activity at 3 min or 15 min after addition of 
excess unlabelled cGMP, relative to before addition of cGMP (+ or -DNA for each strain). All data shown are means with S.D. from triplicate 
determinations. * ; significantly increased with P < 0.05. 
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activity with reduced affinity (from 1.5 nM in the parental 
strain to 2.4-3.3 nM in these mutants); the number of 
binding sites, the dissociation rate and the effect of DNA 
are not very different from those of the parental strain. 
Interestingly, the two mu~:ants KI-2 and KI-7 with a rela- 
tively large but delayed cGMP response both belong to 
this class; the third mutanT: in this class is KI-6 which has a 
very weak cGMP response. The phenotype of class III 
mutants is very pronounced: the affinity of the cGMP-bi- 
nding protein is increased from 1.5 nM to 0.3-0.8 nM, the 
number of detectable binding sites has increased about 
2-fold, dissociation of the cGMP-protein complex is very 
slow and addition of DNA does not alter cGMP-binding 
activity. These data are consistent with the binding activity 
being locked in the S-type. Mutants KI-4 and KI-5 show 
the strongest phenotype, whereas mutant KI-10 is weaker. 
In this respect it is worth mentioning that mutant KI-10 is 
the only dominant mutant. Mutants KI-4 and 5 both show 
a weak cGMP response whereas mutant KI-10 does not 
respond to cAMP or folic acid with an increase of cGMP 
levels. The last class centains one mutant KI-9, which 
shows normal characteristics in respect to affinity and 
dissociation rate, except hat the number of cGMP-binding 
sites is increased about 2.5-fold. It is possible that in this 
mutant here is just more of an otherwise normal cGMP- 
binding protein. 
Upon starvation of Dictyostelium cells the number of 
cGMP-binding sites remains relatively constant during the 
first 4 h of development and then increases about 3-fold 
during the next 8 h of development [18]. Therefore, it 
could be possible that the increased number of cGMP-bi- 
nding sites in mutants KI-4, 5, 9 and 10 is due to an 
enhanced evelopmental program. However, from the ob- 
servations that all KI mutants have little expression of 
developmental markers uch as cAMP receptors and con- 
tact sites A (data not shown), it is unlikely that these 
mutants develop very fast. Therefore, the increased num- 
ber of binding sites is probably due to qualitative (KI-4, 5 
and 10) or quantitative (KI-9) changes of cGMP-binding 
activity. 
In class III mutants KI-4 and KI-5 the dissociating rate 
of bound cGMP is very slow and DNA has no effect on 
this rate; apparently the cGMP-binding protein is locked in 
the S-type. One explanation for these observations could 
be that crude cytosolic fiactions from these mutants con- 
tained large amounts of oligonucleotide fragments, RNA 
and/or DNA. This is unlikely, because after partial purifi- 
cation of the crude cyto:~olic fraction of the mutants by 
DEAE-cellulose, which should remove most of the oligo- 
nucleotides, the cGMP-binding activity still has S-type 
dissociating properties (data not shown). 
The observation that seven out of ten chemotactic mu- 
tants show altered cGMP-binding activity strongly sug- 
gests that this binding protein is involved in the chemotac- 
tic signal transduction pathway leading to myosin 
phosphorylation a d finally directed cell locomotion. On 
the other hand, it may be proposed that the cGMP-binding 
activity is not involved in this chemotactic signal transduc- 
tion pathway and that the abnormalities of cGMP-binding 
activity are due to secondary effects from the mutations in 
all these seven mutants, i.e. they are due to the altered 
cGMP response, altered development or altered chemo- 
taxis. This seems contradicted by the observation that 
mutant KI-8 has normal cGMP-binding activity, but lacks 
guanylyl cyclase activity, basal and receptor-stimulated 
cGMP levels, and shows no cAMP-induced evelopment 
and chemotaxis. Thus the absence of cGMP has no effect 
on the properties of the isolated cGMP-binding protein. 
As all KI mutants belong to different complementation 
groups [9], the finding of 7 'cGMP-binding' mutants ug- 
gests that multiple genes are associated with cGMP-bind- 
ing activity. The number of genes may be less than the 
number of complementation groups. For instance, if the 
cGMP-binding protein functions as a dimer, different mu- 
tations in the same protein may complement each other in 
the diploid. In this respect it is interesting to note that 
mutants KI-4 and KI-5 are nearly identical to each other as 
are mutants KI-2 and KI-7. On the other hand, associated 
proteins may alter the kinetics and activity of the cGMP- 
binding protein. Isolation of the mutated genes from the KI 
mutants and subsequently identification of the mutated 
proteins hould give a better understanding of the cGMP- 
binding protein unit. 
Interestingly, all 7 KI mutants with altered cGMP-bind- 
ing activity also show a diminished production of cGMP in 
response to the chemoattractants cAMP and folic acid 
(Table 4). This could mean that either (1) the cGMP-bind- 
ing protein is an unusual guanylyl cyclase, (2) the cGMP- 
binding protein is involved in guanylyl cyclase activation, 
or (3) that mutants have multiple mutations, one affecting 
cGMP-binding and one affecting uanylyl cyclase activa- 
tion. The first hypothesis unlikely, because mutant KI-8 
with nearly no guanylyi cyclase activity has normal 
cGMP-binding activity, and many other mutants with dif- 
ferent cGMP-binding properties have normal basal guany- 
lyl cyclase activity (including mutants KI-4, 5 and 10); 
moreover, guanylyl cyclase is membrane-bound but the 
cGMP-binding activity is present in the cytosol. Concern- 
ing the second hypothesis, previous experiments by 
Schulkes et al. [21] demonstrate he necessity of a soluble 
protein for optimal magnesium-dependent guanylyl cyclase 
activity. Recently we observed that mutants KI-4 and 5 do 
not possess this soluble protein that activates guanylyl 
cyclase in vitro (Kuwayama and Van Haastert, unpub- 
lished observations). This strongly suggests that the 
cGMP-binding protein regulates guanylyl cyclase activity. 
In this respect, the observation of a soluble cGMP-binding 
protein that is required for optimal magnesium-dependent 
guanylyl cyclase activity in Dictyostelium lysates could 
provide a mechanism how several mutations may affect 
both cGMP-binding properties as well as receptor-stimu- 
lated guanylyl cyclase activity. 
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The detailed analysis of the 10 chemotactic mutants has 
established that only two mutants are not altered in either 
the production of cGMP by guanylyl cyclase or the detec- 
tion of cGMP by the intracellular cGMP-binding protein: 
mutant KI-I is relatively normal in all these properties, but 
still shows no chemotaxis to different chemoattractants, 
whereas mutant KI-3 shows significant chemotactic re- 
sponses to all chemoattractants. The observation that 8 
mutants have altered cGMP functioning places this second 
messenger in the center of chemotactic signal transduction 
in Dictyostelium. 
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